Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
10 A-Rated Dividend Aristocrats For The Ultimate High-Yield SWAN Portfolio
07:20am, Wednesday, 24'th May 2023
The debt ceiling crisis is coming down to the wire. We're possibly already out of time to prevent default and just don't know it. UBS estimates a short default could create a 20% bear market and a one
Invest in These Dividend Growth Stocks Amid Default Fears
09:08am, Tuesday, 23'rd May 2023
Dividend stocks W.W. Grainger (GWW), Graphic Packaging (GPK), PulteGroup (PHM), Walmart (WMT) and Novartis (NVS) could be solid choices for your portfolio.
Novartis (NVS) Up 10.8% YTD on Strong Q1, Pipeline Progress
01:46pm, Friday, 19'th May 2023
Novartis (NVS) gains 10.6% year to date on strong first-quarter results and encouraging data on Kisqali from the NATALEE study.
Novartis Dropping Some Cancer Drugs From Pipeline
12:04pm, Friday, 19'th May 2023
Medicare's new ability to negotiate some drug prices is a "super high concern," according to CEO Vas Narasimhan.
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
08:44am, Thursday, 18'th May 2023
Big pharmaceutical stocks, including Novartis AG NYSE: NVS, Eli Lilly & Co. NYSE: LLY, Merck & Co. NYSE: MRK, and Novo Nordisk A/S NYSE: NVO have been outperforming the broader market recently, even a
What Makes Novartis (NVS) a Strong Momentum Stock: Buy Now?
01:41pm, Wednesday, 10'th May 2023
Does Novartis (NVS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?
11:26am, Wednesday, 10'th May 2023
Here is how Novartis (NVS) and Akebia Therapeutics (AKBA) have performed compared to their sector so far this year.
Here's Why Novartis (NVS) is a Strong Value Stock
11:27am, Tuesday, 09'th May 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Novartis ‘focusing on high-end, innovative medicines,' CEO says
10:24am, Tuesday, 09'th May 2023
Novartis CEO Vas Narasimhan joins Yahoo Finance Live anchors to discuss company earnings, focusing efforts on fighting cancer, consumer health, and cutting roughly 10% of the global healthcare company
5 Dividend Growth Stocks to Buy for Safe Returns
09:54am, Monday, 08'th May 2023
PulteGroup (PHM), Novartis (NVS), Boyd Gaming (BYD), Cummins (CMI) and W.W. Grainger (GWW) could be solid choices for your portfolio.
Novartis (NVS) Could Be a Great Choice
12:55pm, Wednesday, 03'rd May 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes?
V&M Breakouts: Top Long-Term Growth And Dividend Stocks For May 2023
04:51pm, Monday, 01'st May 2023
The May 2022 total return portfolio for 1-year is up +17.09%, and the May 2021 2-year portfolio is up 21.33%, not adjusted for greater than 2%+ dividends. The first May 2020 portfolio had +66.98% 2-ye
Is This Big Pharma Stock a Buy for Dividend Investors?
10:07am, Thursday, 27'th Apr 2023
A strong product portfolio propelled Novartis' results during the first quarter. The company's market-doubling payout appears to be viable.
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
10:21am, Wednesday, 26'th Apr 2023
Basel, April 26, 2023 — Novartis will present new data from its oncology portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, including advancements in breast cancer, p
Novartis (NVS) Tops on Q1 Earnings & Revenues, Ups View
02:26pm, Tuesday, 25'th Apr 2023
Novartis (NVS) beats on earnings and sales in the first quarter, and raises its annual guidance on strong momentum.
